(E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate

(E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP) is an isoprenoid precursor in the non-mevalonate pathway (also known as the MEP/DOXP pathway) of isoprenoid biosynthesis. This pathway is responsible for the biosynthesis of many crucial compounds, including certain vitamins, quinones, and terpenoids, in bacteria, plastids of plants, and some protozoa. HMB-PP is considered a key intermediate in this pathway, lying downstream of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MEC) and upstream of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), which are direct precursors of various terpenoids.
Biosynthesis[edit]
HMB-PP is synthesized from 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MEC) in a reaction catalyzed by the enzyme HMB-PP synthase. This step involves the removal of a phosphate group and the formation of the HMB-PP molecule, which contains a conjugated ene-diol structure, characteristic of its role as a chemical intermediate.
Function[edit]
In the non-mevalonate pathway, HMB-PP serves as a direct precursor to isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). These molecules are essential building blocks for the synthesis of all isoprenoids, a diverse class of biological molecules that includes carotenoids, steroids, and dolichols. HMB-PP is thus central to the metabolic processes that produce these compounds, which are vital for cell membrane structure, hormones, vitamins, and energy carriers among others.
Importance in Research and Medicine[edit]
HMB-PP is of significant interest in both basic and applied research due to its role in the non-mevalonate pathway, which is present in many pathogens but absent in humans. This makes the enzymes of this pathway, including HMB-PP synthase, potential targets for the development of new antibiotics and antimalarial drugs. Furthermore, HMB-PP is known to be a potent activator of human Vγ9Vδ2 T cells, a type of T cell that plays a role in the immune response to infection and cancer. This has implications for the development of immune therapies and vaccines.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian